胆管癌:在精准医学时代的病理和分子分类
Purva Gopal1, Marie E Robert2, Xuchen Zhang2
1From the Department of Pathology, UT Southwestern Medical Center, Dallas, Texas (Gopal).
Archives of pathology & laboratory medicine
|June 16, 2023
概括
诊断胆管癌 (CCA),一种复杂的胆管癌,是一项挑战. 本综述涵盖了现代诊断方法,包括组织病理学和遗传检测,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 病理学 病理学 病理学
背景情况:
- 胆管癌 (CCA) 是一种具有诊断挑战的异质胆管癌.
- 诊断通常发生在较晚的阶段,由瘤难以接近和与转移性疾病的差异化而复杂化.
研究的目的:
- 提供对胆道管癌最先进的诊断方法的见解.
- 审查目前用于准确CCA诊断,分类和预后的方法.
主要方法:
- 使用PubMed.com进行了全面的文献综述.
- 纳入作者临床经验.
- 诊断方式的分析,包括临床表现,组织病理学,分期和遗传检测.
主要成果:
- CCA的分类包括具有不同的亚型和生长模式的肝内和肝外类型.
- 免疫组织化学有助于将CCA与其他癌症区分开来,尽管缺乏特定的特征.
- 下一代测序揭示了CCA亚型的独特基因组概况和潜在的治疗点.
结论:
- 准确的诊断和CCA的分类对于治疗决策和预后至关重要.
- 详细的组织病理学和分子评估对于管理这种异质癌症至关重要.
- 整合临床,组织病理学和分子数据为CCA诊断提供了一种全面的方法.
相关概念视频
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


